Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin
Crossref DOI link: https://doi.org/10.1007/s10549-016-3729-8
Published Online: 2016-02-25
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Turturro, Sanja B.
Najor, Matthew S.
Ruby, Carl E.
Cobleigh, Melody A.
Abukhdeir, Abde M. http://orcid.org/0000-0003-1172-5819
Funding for this research was provided by:
Pink Pumpkin Foundation
License valid from 2016-02-01